EDITORIAL BOARD Steven Vogl, MD Medical Oncologist, New York City |
San Antonio—The 2013 San Antonio Breast Cancer Symposium (SABCS) included two important presentations on adjuvant bisphosphonates for breast cancer: a plenary lecture by Michael Gnant, MD, of the Medical University of Vienna in Austria; and an oral presentation of data from an Oxford Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) individual patient meta-analysis on the utility of bisphosphonates